prof. RNDr. Šárka Pospíšilová, Ph.D.

Vice-rector for research and doctoral studies, Masaryk University

office: bldg. E35/257
Kamenice 753/5
625 00 Brno

phone:	+420 549 49 1038, +420 777 926 661
e‑mail:

social and academic networks:

Basic information

Supervision

Qualifications

Publications

Type

Total number of publications: 979

2013

Reactivation of selected p53 mutants in B-cell tumor cell lines using targeted small molecules

JAŠKOVÁ Zuzana ŠEBEJOVÁ Ludmila POSPÍŠILOVÁ Šárka TRBUŠEK Martin

Conference abstract

Year: 2013, type: Conference abstract
Reaktivace vybraných p53 mutantů u B-buněčných nádorových linií prostřednictvím malých cílených molekul

JAŠKOVÁ Zuzana ŠEBEJOVÁ Ludmila POSPÍŠILOVÁ Šárka TRBUŠEK Martin

Conference abstract

Year: 2013, type: Conference abstract
Recommendations on TP53 mutational analysis in chronic lymphocytic leukemia (CLL)

POSPÍŠILOVÁ Šárka

Requested lectures

Year: 2013, type: Requested lectures
Role of Wnt-5A and non-canonical Wnt signaling in chronic lymphocytic leukemia

KAUCKÁ Markéta JANOVSKÁ Pavlína PAVLOVÁ Šárka PLEVOVÁ Karla MÁDROVÁ Hana POPPOVÁ Lucie POSPÍŠILOVÁ Šárka BRYJA Vítězslav

Conference abstract

Year: 2013, type: Conference abstract
SF3B1 mutations frequently occur with both ATM mutations and TP53 mutations in CLL patients

NAVRKALOVÁ Veronika MALČÍKOVÁ Jitka KANTOROVÁ Barbara ŠEBEJOVÁ Ludmila PLEVOVÁ Karla MRÁZ Marek DOUBEK Michael BRYCHTOVÁ Yvona ŠMARDOVÁ Jana MAYER Jiří POSPÍŠILOVÁ Šárka TRBUŠEK Martin

Conference abstract

Year: 2013, type: Conference abstract
Stanovení prognózy pacientů s chronickou lymfocytární leukémií (CLL)

LIBRA Antonín JURČÍČKOVÁ Z. PLEŠINGEROVÁ Hana PLEVOVÁ Karla TICHÝ Boris BRYJA Vítězslav POSPÍŠILOVÁ Šárka

Conference abstract

Year: 2013, type: Conference abstract
Synthetic lethality in p53 mutated B-cell mylignancies: Chk-1 inhibition and DNA-PK inhibition effect in cell lines and primary CLL cells

ZEMANOVÁ Jana ŠEBEJOVÁ Ludmila PARUCH Kamil HYLSE Ondřej POSPÍŠILOVÁ Šárka MAYER Jiří TRBUŠEK Martin

Conference abstract

Year: 2013, type: Conference abstract
The BCR-ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy.

MALČÍKOVÁ Jitka RÁZGA Filip JURČEK Tomáš DVOŘÁKOVÁ Dana ŽÁČKOVÁ Daniela TOŠKOVÁ Hana ŠEBEJOVÁ Ludmila ŠMARDOVÁ Jana OLTOVÁ Alexandra VAŇKOVÁ Gabriela JURAČKOVÁ Lenka TRBUŠEK Martin POSPÍŠILOVÁ Šárka MAYER Jiří RÁČIL Zdeněk

Article in Periodical

Leukemia & Lymphoma, year: 2013, volume: 54, edition: 9, DOI
The expression of a single microRNA -miR-34a - is a reliable marker for impairment of TP53-pathway in chronic lymphocytic leukemia

MRÁZ Marek ČERNÁ Kateřina MUSILOVÁ Kateřina MALČÍKOVÁ Jitka PLEVOVÁ Karla PAVLOVÁ Šárka TICHÝ Boris BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří TRBUŠEK Martin POSPÍŠILOVÁ Šárka

Conference abstract

Year: 2013, type: Conference abstract
The expression of micrRNA-34a is a highly reliable for impairment of p53-pathway in CLL: development of clinically applicable assay

MRÁZ Marek ČERNÁ Kateřina MUSILOVÁ Kateřina MALČÍKOVÁ Jitka PLEVOVÁ Karla PAVLOVÁ Šárka TICHÝ Boris BRYCHTOVÁ Yvona DOUBEK Michael MAYER Jiří TRBUŠEK Martin POSPÍŠILOVÁ Šárka

Conference abstract

Year: 2013, type: Conference abstract

Projects

Teaching